Pre-market Hot Trades in US Stocks

Bloom Energy is up 4.02% in pre-market trading. Based on recent key news:

1. On July 22, Bloom Energy announced a $1.7 billion deal with Nebius AI to provide fuel cell systems, driving the stock price up 14.28%. JP Morgan raised the target price to $346 and maintained an overweight rating, believing that data center grid connection issues are favorable for Bloom's technology.

2. On July 21, Morgan Stanley participated in Bloom Energy's project investment, providing senior debt financing to support its power solutions for AI computing companies, leading to a 15% surge in stock price.

3. On July 21, market rumors surfaced that Oracle's natural gas pipeline application was rejected, affecting Bloom Energy's orders, causing the stock price to drop 8.17%. The demand for AI power is growing, and the industry outlook is optimistic.

IREN is up 3.42% in pre-market trading. Based on recent news:

1. On July 20, IREN announced a $2.8 billion AI cloud contract with industry giants like Microsoft and NVIDIA, raising its annual recurring revenue target for 2026 to over $4 billion. This news drove the stock price up 14.44% during the session.

2. On July 20, IREN rose 7.97% in pre-market trading as the company signed multi-year AI cloud contracts with leading AI developers, with advance payments covering 45% of GPU capital expenditures, leading to optimistic sentiment in the data center sector, with HUT rising nearly 10%.

3. On July 21, IREN surged 19.48% during the session as the company announced that the new contracts alleviated investor concerns about high build-out costs and dilution risks. The demand for AI cloud services continues to grow, and the industry outlook is optimistic.

Top Gainers in Pre-market US Stocks

Rokos, up 119.54% in pre-market trading, has no significant recent news. Trading is active, with clear capital flows, and considering sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation.

Eshallgo, up 47.19% in pre-market trading, has no significant recent news. Trading is active, with clear capital flows, and considering sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation.

Zhengye Biotechnology is up 27.54% in pre-market trading. Based on recent key news:

1. On July 21, Zhengye Biotechnology issued a statement explaining the unusual trading of its Class A common stock. The company focuses on the research and sales of veterinary vaccines in China, and this announcement attracted market attention, driving the stock price up.

2. On July 21, Zhengye Biotechnology released original content via GlobeNewswire, emphasizing its expertise and market position in the veterinary vaccine field, further boosting investor confidence and leading to a significant stock price increase. The demand for veterinary vaccines is growing, and the market is active